Pharmacy Question for the Week of August 27, 2018

Pharmacy Compliance Question of the Week


The FDA recently approved a biosimilar called Fulphila. Is there a HCPCS code yet for it?


The following code will be implemented on October 1, 2018, according to the Centers for Medicare & Medicaid Services (CMS) in MM10834. (For this memo, go to

Q5108 Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg

The code is effective for dates of service on or after July 12, 2018 and will be paid by Medicare.

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.